Strategies for Improving Care

Revision as of 19:02, 6 December 2016 by Shivani Chaparala (talk | contribs)
Jump to navigation Jump to search

2016 ADA Guideline Recommendations

Types of Diabetes Mellitus

Main Diabetes Page

Diabetes type I

Diabetes type II

Gestational Diabetes Mellitus

2016 ADA Standard of Medical Care Guideline Recommendations

Strategies for Improving Care

Classification and Diagnosis of Diabetes

Foundations of Care and Comprehensive Medical Evaluation

Diabetes Self-Management, Education, and Support
Nutritional Therapy

Prevention or Delay of Type II Diabetes

Glycemic Targets

Obesity Management for Treatment of Type II Diabetes

Approaches to Glycemic Treatment

Cardiovascular Disease and Risk Management

Hypertension and Blood Pressure Control
Lipid Management
Antiplatelet Agents
Coronary Heart Disease

Microvascular Complications and Foot Care

Diabetic Kidney Disease
Diabetic Retinopathy
Diabetic Neuropathy
Diabetic Footcare

Older Adults with Diabetes

Children and Adolescents with Diabetes

Management of Cardiovascular Risk Factors in Children and Adolescents with Diabetes
Microvascular Complications in Children and Adolescents with Diabetes

Management of Diabetes in Pregnancy

Diabetes Care in the Hospital Setting

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shivani Chaparala M.B.B.S [2]; Seyedmahdi Pahlavani, M.D. [3]; Tarek Nafee, M.D. [4]

2016 ADA Standards of Medical Care in Diabetes Guidelines

"1. A patient-centered communication style that incorporates patient preferences, assesses literacy and numeracy, and addresses cultural barriers to care should be used. (Level of Evidence: B)"
"2. Treatment decisions should be timely and based on evidence-based guidelines that are tailored to individual patient preferences, prognoses, and co- morbidities. (Level of Evidence: B)"
"3. Care should be aligned with components of the Chronic Care Model to ensure productive interactions between a prepared proactive practice team and an informed activated patient. (Level of Evidence: A)"
"4. When feasible, care systems should support team-based care, community involvement, patient registries, and decision support tools to meet patient needs. (Level of Evidence: B)"

Food Insecurity

"1. Providers should evaluate hyperglycemia and hypoglycemia in the context of food insecurity and propose solutions accordingly. (Level of Evidence: A)"
"2. Providers should recognize that homelessness, poor literacy, and poor numeracy often occur with food insecurity, and appropriate resources should be made avail- able for patients with diabetes. (Level of Evidence: A)"

Cognitive Dysfunction

"1. Intensive glucose control is not ad- vised for the improvement of poor cognitive function in hyperglycemic individuals with type 2 diabetes. (Level of Evidence: B)"
"2. In individuals with poor cognitive function or severe hypoglycemia, glycemic therapy should be tailored to avoid significant hypoglycemia. (Level of Evidence: C)"
"3. In individuals with diabetes at high cardiovascular risk, the cardiovascular benefits of statin therapy outweigh the risk of cognitive dysfunction. (Level of Evidence: A)"
"4. If a second-generation antipsychotic medication is prescribed, changes in weight, glycemic control, and cho- lesterol levels should be carefully monitored and the treatment regi- men should be reassessed. (Level of Evidence: C)"

Diabetes Care in Patients With HIV

"1. Patients with HIV should be screened for diabetes and prediabetes with a fasting glucose level before starting antiretroviral therapy and 3 months after starting or changing it. If initial screening results are normal, check- ing fasting glucose each year is ad- vised. If prediabetes is detected, continue to measure levels every 3–6 months to monitor for pro- gression to diabetes. (Level of Evidence: E)"

References

Template:WHTemplate:WS